حجز موعد
تواصل مباشر
EN

الأستاذ المشارك الدكتور إركان جوره

الاهتمامات الطبية

تواصل معنا و احصل على استشارة مجانية

التعليم والتخصص

  • 1999: كلية الطب، جامعة أوندوكوز مايس
  • 2007: تخصص في الأمراض الباطنية، جامعة سليمان دميريل

خبرات الدكتور إركان جوره

  • 1999 – 2000: مركز أوموتلو الصحي، أكداغماديني / يوزغات – طبيب عام
  • 2000 – 2002: كلية الطب، جامعة أوندوكوز مايس – مساعد طبيب في جراحة الأعصاب
  • 2002 – 2008: كلية الطب، جامعة سليمان دميريل – مساعد طبيب في الأمراض الباطنية
  • 2008 – 2009: مستشفى صفْرانبول الحكومي – أخصائي الأمراض الباطنية
  • 2009 – 2010: مستوصف قيادة الجيش الثالث – أرزينجان – طبيب برتبة ملازم
  • 2010 – 2012: مستشفى صفْرانبول الحكومي – أخصائي الأمراض الباطنية
  • 2012 – 2016: جامعة رجب طيب أردوغان – كلية الطب – عضو هيئة تدريس في قسم الأمراض الباطنية
  • 2017 – 2018: مستشفى إرْدم الخاص – تشاملجا
  • 2019 – 2021: مستشفى أوتا & جينيميد الخاص
  • 2021: مستشفى إثيكا الخاص
  • 2021 – 2022: مستشفى ميديلابف – باغجلار
  • 2022 – 2024: مستشفى ميديلابف – بيليك دوزو
  • 2024 – حتى الآن: مستشفى ميديكانا – بهتشلي إيفلر
  • 2024 – حتى الآن: مستشفى İstinye Üniversitesi Medical Park – غازي عثمان باشا

الدورات والشهادات

  • 2003: الدورة السابعة لدعم الحياة القلبية المتقدمة – دنيزلي
  • 2004: الدورة الثانية لجمعية ارتفاع ضغط الدم التركية – أنطاليا
  • 2004: تدريب على الأحداث الضائرة والالتزام بالممارسات السريرية الجيدة – إسطنبول
  • 2004: الدورة الأولى لجمعية التغذية التركية – أنطاليا
  • 2005: دورة مهارات العرض – إسبرطة
  • 2006: الأساليب والتطبيقات الحديثة في البحوث السريرية – إسبرطة
  • 2006: دورة تدريبية في الروماتولوجيا لطلاب التخصص الدقيق – إزمير
  • 2014: دورة الشهادات للجنة الأخلاقيات في الدراسات السريرية – سامسون

العضويات المهنية

  • غرفة أطباء إسطنبول
  • الجمعية التركية لأطباء الباطنة (TİHUD)
  • عضو مجلس التحرير في مجلة Lipids in Health and Disease منذ عام 2022 وحتى الآن
  1. Pihtili Taş N, Aydogan Baykara R, Kamanli A, Gurbuz A, Cure E, Cumhur Cure M, Erdem M, Tasar Yildirim T. Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome. Arch Rheumatol. 2024;39(3):375-383. doi: 10.46497/ArchRheumatol.2024.10462.
  2. Cumhur Cure M, Cure E. Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19? Curr Pharm Des. 2024;30(15):1149-1156. doi: 10.2174/0113816128300162240322075423.
  3. Cumhur Cure M, Cure E. Severe acute respiratory syndrome coronavirus 2 may cause liver injury via Na+/H+ exchanger. World J Virol. 2023 Jan 25;12(1):12-21. doi: 10.5501/wjv.v12.i1.12.
  4. Cure E, Cumhur Cure M. Insulin may increase disease severity and mortality of COVID-19 through Na+/H+ exchanger in patients with type 1 and type 2 diabetes mellitus. J Endocrinol Invest. 2023 Apr;46(4):845-847. doi: 10.1007/s40618-022-01951-y.
  5. Cure MC, Cure E. Prolonged NHE Activation may be both Cause and Outcome of Cytokine Release Syndrome in COVID-19. Curr Pharm Des. 2022;28(22):1815-1822. doi: 10.2174/1381612828666220713121741.
  6. Aydogan Baykara R, Yilmaz PD, Göktepe MH, Kadiyoran C, Ogul M, Kucuk A, Cumhur Cüre M, Cüre E. Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet’s disease. Clin Exp Hypertens. 2022 Jul 4;44(5):480-486. doi: 10.1080/10641963.2022.2071921.
  7. Ozdemir A, Tumkaya L, Kalcan S, Uyan M, Karakaya A, Demiral G, Celik Samanci T, Mercantepe T, Cumhur Cüre M, Cüre E. The effects of TNF-α inhibitors on carbon tetrachloride-induced nephrotoxicity. Clin Exp Hypertens. 2022 Apr 3;44(3):291-296. doi: 10.1080/10641963.2021.2018600.
  8. Cure E, Cumhur Cure M. Strong relationship between cholesterol, low-density lipoprotein receptor, Na+/H+ exchanger, and SARS-COV-2: this association may be the cause of death in the patient with COVID-19. Lipids Health Dis. 2021 Dec 13;20(1):179. doi: 10.1186/s12944-021-01607-5.
  9. Demir S, Kucuk A, Altas M, Cure E. Restless Leg Syndrome and Sleep Disorders in Patients with Rheumatoid Arthritis and Its Relation with Anemia Parameters. Acta Medica (Hradec Kralove). 2021;64(3):137-144. doi: 10.14712/18059694.2021.24.
  10. Cumhur Cure M, Cure E. Effects of the Na+/H+ Ion Exchanger on Susceptibility to COVID-19 and the Course of the Disease. J Renin Angiotensin Aldosterone Syst. 2021 Jun 15;2021:4754440. doi: 10.1155/2021/4754440.
  11. Cure E, Kucuk A, Cure MC. Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors. Indian J Pharmacol. 2021 May-Jun;53(3):226-228. doi: 10.4103/ijp.IJP_615_20.
  12. Kucuk A, Baykara RA, Tuzcu A, Omma A, Cure MC, Cure E, Acet GK, Dogan E. Could ferritin, vitamin B12, and vitamin D play a role in the etiopathogenesis of fibromyalgia syndrome? Rom J Intern Med. 2021 Nov 20;59(4):384-393. doi: 10.2478/rjim-2021-0022.
  13. Cure E, Sirin H, Cure MC, Sahin DA. Dapagliflozin-induced long-term and severe anorexia and weight loss: An extraordinary case. Indian J Pharmacol. 2021 Mar-Apr;53(2):174-175. doi: 10.4103/ijp.IJP_785_19.
  14. Aydin I, Sehitoglu I, Ozer E, Kalkan Y, Tumkaya L, Cure MC, Cure E. High dose zoledronic acid increases ischemia-reperfusion damage of the liver. Eur Rev Med Pharmacol Sci. 2021 May;25(9):3567-3575. doi: 10.26355/eurrev_202105_25839.
  15. Gıca Ş, Akkubak Y, Aksoy ZK, Küçük A, Cüre E. Effects of the COVID-19 pandemic on psychology and disease activity in patients with ankylosing spondylitis and rheumatoid arthritis. Turk J Med Sci. 2021 Aug 30;51(4):1631-1639. doi: 10.3906/sag-2011-188.
  16. Aydoğan Baykara R, Küçük A, Tuzcu A, Tuzcu G, Cüre E, Uslu AU, Omma A. The relationship of serum visfatin levels with clinical parameters, flow-mediated dilation, and carotid intima-media thickness in patients with ankylosing spondylitis. Turk J Med Sci. 2021 Aug 30;51(4):1865-1874. doi: 10.3906/sag-2012-351.
  17. Cure E, Cure MC. Comment on Triglycerides-to-HDLC Ratio as a Marker of Cardiac Disease and Vascular Risk Factors in Adults. J Coll Physicians Surg Pak. 2020 Dec;30(12):1357. doi: 10.29271/jcpsp.2020.12.1357.
  18. Cure E, Cumhur Cure M, Vatansev H. Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension. J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972015. doi: 10.1177/1470320320972015.
  19. Cure E, Ilcol TB, Cumhur Cure M. Angiotensin II, III, and IV may be important in the progression of COVID-19. J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972019. doi: 10.1177/1470320320972019.
  20. Cure E, Cumhur Cure M. Alpha-lipoic acid may protect patients with diabetes against COVID-19 infection. Med Hypotheses. 2020 Oct;143:110185. doi: 10.1016/j.mehy.2020.110185.
  21. Vatansev H, Kadiyoran C, Cumhur Cure M, Cure E. COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection. Med Hypotheses. 2020 Oct; 143:110091. doi: 10.1016/j.mehy.2020.110091.
  22. Cumhur Cure M, Kucuk A, Cure E. NSAIDs may increase the risk of thrombosis and acute renal failure in patients with COVID-19 infection. Therapie. 2020 Jul-Aug;75(4):387-388. doi: 10.1016/j.therap.2020.06.012.
  23. Cure E, Cure MC. COVID-19 May Predispose to Thrombosis by Affecting Both Vascular Endothelium and Platelets. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620933945. doi: 10.1177/1076029620933945.
  24. Cure E, Cure MC. Comment on “The Clinical Importance of the Plasma Atherogenic Index, Other Lipid Indexes, and Urinary Sodium and Potassium Excretion in Patients with Stroke”. Eurasian J Med. 2020 Jun;52(2):227-228. doi: 10.5152/eurasianjmed.2020.20007.
  25. Yücel A, Yücel H, Aydemir F, Cüre E, Eryılmaz MA, Çizmecioğlu HA, Küçük A. Determination of hearing levels in gout patients and factors affecting hearing levels such as the dislipidemia, hemoglobin levels and hyperuricemia. Am J Otolaryngol. 2020 Sep-Oct;41(5):102565. doi: 10.1016/j.amjoto.2020.102565.
  26. Cure E, Cumhur Cure M. COVID-19 may affect the endocrine pancreas by activating Na+/H+ exchanger 2 and increasing lactate levels. J Endocrinol Invest. 2020 Aug;43(8):1167-1168. doi: 10.1007/s40618-020-01307-4.
  27. Kucuk A, Cumhur Cure M, Cure E. Can COVID-19 cause myalgia with a completely different mechanism? A hypothesis. Clin Rheumatol. 2020 Jul;39(7):2103-2104. doi: 10.1007/s10067-020-05178-1.
  28. Cure E, Kucuk A, Cumhur Cure M. Cyclosporine therapy in cytokine storm due to coronavirus disease 2019 (COVID-19). Rheumatol Int. 2020 Jul;40(7):1177-1179. doi: 10.1007/s00296-020-04603-7.
  29. Cumhur Cure M, Kucuk A, Cure E. Colchicine may not be effective in COVID-19 infection; it may even be harmful? Clin Rheumatol. 2020 Jul;39(7):2101-2102. doi: 10.1007/s10067-020-05144-x.
  30. Cure E, Cumhur Cure M. Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):405-406. doi: 10.1016/j.dsx.2020.04.024.
  31. Cure E, Cumhur Cure M. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic. Diabetes Metab Syndr. 2020 Jul-Aug;14(4):349-350. doi: 10.1016/j.dsx.2020.04.019.
  32. Kadiyoran C, Zengin O, Cizmecioglu HA, Tufan A, Kucuksahin O, Cure MC, Cure E, Kucuk A, Ozturk MA. Monocyte to Lymphocyte Ratio, Neutrophil to Lymphocyte Ratio, and Red Cell Distribution Width are the Associates with Gouty Arthritis. Acta Medica (Hradec Kralove). 2019;62(3):99-104. doi: 10.14712/18059694.2019.132.
  33. [Image of gouty arthritis crystals]
  34. Kadiyoran C, Cizmecioglu HA, Cure E, Yildirim MA, Yilmaz PD. Liver metastasis in colorectal cancer: evaluation of segmental distribution. Prz Gastroenterol. 2019;14(3):188-192. doi: 10.5114/pg.2019.88168.
  35. Tuzcu A, Baykara RA, Alışık M, Omma A, Acet GK, Dogan E, Cure MC, Duygun F, Cure E, Erel O. Alteration of Thiol-Disulfide Homeostasis in Fibromyalgia Syndrome. Acta Medica (Hradec Kralove). 2019;62(1):12-18. doi: 10.14712/18059694.2019.40.
  36. Kurt A, Kalkan Y, Turut H, Cure MC, Tumkaya L, Cure E. Topiramate Reduces Aortic Cross-Clamping-Induced Lung Injury in Male Rats. Acta Medica (Hradec Kralove). 2018;61(4):144-149. doi: 10.14712/18059694.2018.133.
  37. Icli A, Cure MC, Cure E, Arslan S, Unal M, Sakiz D, Ozucan M, Toker A, Turkmen K, Kucuk A. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet’s Disease. Acta Medica (Hradec Kralove). 2018;61(3):86-92. doi: 10.14712/18059694.2018.123.
  38. Yücel H, Yücel A, Arbağ H, Cure E, Eryilmaz MA, Özer AB. Effect of statins on hearing function and subjective tinnitus in hyperlipidemic patients. Rom J Intern Med. 2019 Jun 1;57(2):133-140. doi: 10.2478/rjim-2018-0035.
  39. Sandikci SC, Colak S, Aydoğan Baykara R, Öktem A, Cüre E, Omma A, Kucuk A. Evaluation of restless legs syndrome and sleep disorders in patients with psoriatic arthritis. Z Rheumatol. 2019 Dec;78(10):987-995. English. doi: 10.1007/s00393-018-0562-y.
  40. Tuzcu A, Baykara RA, Omma A, Acet GK, Dogan E, Cure MC, Sandikci SC, Cure E, Neşelioğlu S, Erel O. Thiol/Disulfide homeostasis in patients with rheumatoid arthritis. Rom J Intern Med. 2019 Mar 1;57(1):30-36. doi: 10.2478/rjim-2018-0025.
  41. Baykara RA, Tuzcu A, Omma A, Acet GK, Dogan E, Aydin A, Cure MC, Cure E, Kucuk A, Erel O. Evaluation of serum thiol/disulfide homeostasis in patients with ankylosing spondylitis by a novel method. North Clin Istanb. 2018 Aug 8;6(4):348-354. doi: 10.14744/nci.2018.37132.
  42. Karadag Z, Sehitoglu T, Cure MC, Rakici H, Ayvaz MA, Bedir R, Kizilkaya B, Şahin OZ, Cure E. Helicobacter pylori can be related to carotid intima-media thickness, epicardial adipose tissue thickness and serum neutrophil gelatinase-associated lipocalin (NGAL) levels. Bratisl Lek Listy. 2018;119(5):302-307. doi: 10.4149/BLL_2018_057.
  43. Cure E, Icli A, Uslu AU, Sakiz D, Cure MC, Baykara RA, Yavuz F, Arslan S, Kucuk A. Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS. Clin Rheumatol. 2018 May;37(5):1273-1280. doi: 10.1007/s10067-018-4027-0.
  44. Uslu AU, Kucuk A, Icli A, Cure E, Sakiz D, Arslan S, Baykara RA. Plasma Atherogenic Index is an Independent Indicator of Subclinical Atherosclerosis in Systemic Lupus Erythematosus. Eurasian J Med. 2017 Oct;49(3):193-197. doi: 10.5152/eurasianjmed.2017.17143.
  45. Cüre MC, Cüre E, Kalkan Y, Kırbaş A, Tümkaya L, Yılmaz A, Türkyılmaz AK, Şehitoğlu İ, Yüce S. Infliximab Modulates Cisplatin-Induced Hepatotoxicity in Rats. Balkan Med J. 2016 Sep;33(5):504-511. doi: 10.5152/balkanmedj.2016.150576.
  46. Kurt A, Turut H, Acipayam A, Kirbas A, Yuce S, Cumhur Cure M, Cure E. Investigation of surfactant protein-D and interleukin-6 levels in patients with blunt chest trauma with multiple rib fractures and pulmonary contusions: a cross-sectional study in Black Sea Region of Turkey. BMJ Open. 2016 Oct 12;6(10):e011797. doi: 10.1136/bmjopen-2016-011797.
  47. Cure MC, Cure E, Kalkan Y, Tumkaya L, Aydin I, Kirbas A, Efe H, Kurt A, Yuce S. The Protective Effect of Adalimumab on Renal Injury in a Model of Abdominal Aorta Cross-Clamping. Adv Clin Exp Med. 2016 Mar-Apr;25(2):219-26. doi: 10.17219/acem/33250.
  48. Sehitoglu I, Bedir R, Cure E, Cure MC, Yuce S, Dilek N. Evaluation of the relationship between c-Kit expression and mean platelet volume in classic Kaposi’s sarcoma. An Bras Dermatol. 2016 Jul-Aug;91(4):430-5. doi: 10.1590/abd1806-4841.20164331.
  49. Kurt A, Tumkaya L, Yuce S, Turut H, Cure MC, Sehitoglu I, Kalkan Y, Pusuroglu G, Cure E. The protective effect of infliximab against carbon tetrachloride-induced acute lung injury. Iran J Basic Med Sci. 2016 Jun;19(6):685-91.
  50. Icli A, Cure E, Uslu AU, Sakiz D, Cure MC, Ozucan M, Baykara RA, Karakoyun A, Balta S, Ozturk C, Arslan S, Kucuk A. The Relationship Between Atherogenic Index and Carotid Artery Atherosclerosis in Familial Mediterranean Fever. Angiology. 2017 Apr;68(4):315-321. doi: 10.1177/0003319716659220.
  51. Cure E, Icli A, Ugur Uslu A, Aydoğan Baykara R, Sakiz D, Ozucan M, Yavuz F, Arslan S, Cumhur Cure M, Kucuk A. Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease. Z Rheumatol. 2017 Apr;76(3):259-266. English. doi: 10.1007/s00393-016-0141-z.
  52. Kucuk A, Ugur Uslu A, Icli A, Cure E, Arslan S, Turkmen K, Toker A, Kayrak M. The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis. Z Rheumatol. 2017 Feb;76(1):58-63. English. doi: 10.1007/s00393-016-0092-4.
  53. Eryilmaz MA, Yucel A, Cure E, Sakiz D, Koder A, Kucuk A, Tunc R. The evaluation of cochlear functions in Familial Mediterranean Fever. Eur Arch Otorhinolaryngol. 2016 Dec;273(12):4119-4126. doi: 10.1007/s00405-016-4067-5.
  54. Kirbas S, Kirbas A, Tufekci A, Cumhur Cure M, Cakmak S, Yazici T, Cure E. Serum levels of homocysteine, asymmetric dimethylarginine and nitric oxide in patients with Parkinson’s disease. Acta Clin Belg. 2016 Apr;71(2):71-5. doi: 10.1080/17843286.2016.1138592.
  55. Erkut A, Cure MC, Kalkan Y, Balik MS, Guvercin Y, Yaprak E, Yuce S, Sehitoglu I, Cure E. Protective effects of thymoquinone and alpha-tocopherol on the sciatic nerve and femoral muscle due to lower limb ischemia-reperfusion injury. Eur Rev Med Pharmacol Sci. 2016;20(6):1192-202.
  56. Erkut A, Tumkaya L, Balik MS, Kalkan Y, Guvercin Y, Yilmaz A, Yuce S, Cure E, Sehitoglu I. The effect of prenatal exposure to 1800 MHz electromagnetic field on calcineurin and bone development in rats. Acta Cir Bras. 2016 Feb;31(2):74-83. doi: 10.1590/S0102-865020160020000001.
  57. Kurt A, Tumkaya L, Kalkan Y, Turut H, Cure MC, Cure E, Sehitoglu I, Bilgin H, Usta M. Is adalimumab protective in ischemia-reperfusion injury in lung? Iran J Basic Med Sci. 2015 Nov;18(11):1093-9.
  58. Icli A, Cure E, Cumhur Cure M, Uslu AU, Balta S, Arslan S, Sakiz D, Kucuk A. Novel myokine: irisin may be an independent predictor for subclinic atherosclerosis in Behçet’s disease. J Investig Med. 2016 Apr;64(4):875-81. doi: 10.1136/jim-2015-000044.
  59. Icli A, Cure E, Cure MC, Uslu AU, Balta S, Mikhailidis DP, Ozturk C, Arslan S, Sakız D, Sahin M, Kucuk A. Endocan Levels and Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus. Angiology. 2016 Sep;67(8):749-55. doi: 10.1177/0003319715616240.
  60. Yüce S, Cüre E, Çiçek Y, Cumhur Cüre M, Yılmaz A, Kızılkaya B. Evaluation of aortic stiffness in Gilbert syndrome patients: a protective effect of elevated bilirubin levels. Turk Kardiyol Dern Ars. 2015 Oct;43(7):599-606. doi: 10.5543/tkda.2015.44457.
  61. Sahin FK, Sahin SB, Ural UM, Cure MC, Senturk S, Tekin YB, Balik G, Cure E, Yuce S, Kirbas A. Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome. Bosn J Basic Med Sci. 2015 Jul 9;15(3):57-63. doi: 10.17305/bjbms.2015.432.
  62. Sehitoglu I, Tumkaya L, Kalkan Y, Bedir R, Cure MC, Zorba OU, Cure E, Yuce S. Biochemical and histopathological effects on the rat testis after exposure to electromagnetic field during fetal period. Arch Esp Urol. 2015 Jul-Aug;68(6):562-8.
  63. Erturk A, Cure MC, Cure E, Kurt A, Cicek AC, Yuce S. Clinical potential of resistin as a novel prognostic biomarker for cellulitis. Exp Ther Med. 2015 May;9(5):1875-1880. doi: 10.3892/etm.2015.2311.
  64. Sehitoglu I, Tumkaya L, Bedir R, Ozer E, Cure MC, Kalkan Y, Yuce S, Cure E. Protective Effect of Infliximab Against Carbon Tetrachloride-Induced Hepatotoxicity. J Environ Pathol Toxicol Oncol. 2015;34(2):175-82. doi: 10.1615/jenvironpatholtoxicoloncol.2015013126.
  65. Kurt A, Tumkaya L, Turut H, Cure MC, Cure E, Kalkan Y, Sehitoglu I, Acipayam A. Protective Effects of Infliximab on Lung Injury Induced by Methotrexate. Arch Bronconeumol. 2015 Nov;51(11):551-7. English, Spanish. doi: 10.1016/j.arbres.2015.03.018.
  66. Yerci O, Sehitoglu I, Ugras N, Cubukcu E, Yuce S, Bedir R, Cure E. Somatostatin receptor 2 and 5 expressions in gastroenteropancreatic neuroendocrine tumors in Turkey. Asian Pac J Cancer Prev. 2015;16(10):4377-81. doi: 10.7314/apjcp.2015.16.10.4377.
  67. Kirbas A, Cure MC, Kalkan Y, Cure E, Tumkaya L, Sahin OZ, Yuce S, Kizilkaya B, Pergel A. Effect of infliximab on renal injury due to methotrexate in rat. Iran J Kidney Dis. 2015 May;9(3):221-9.
  68. Cure E, Kirbas A, Tumkaya L, Cure MC, Kalkan Y, Yilmaz A, Yuce S. Protective effect of infliximab on methotrexate-induced liver injury in rats: unexpected drug interaction. J Cancer Res Ther. 2015 Jan-Mar;11(1):164-9. doi: 10.4103/0973-1482.140809.
  69. Cure MC, Cure E, Tumkaya L, Kalkan Y, Aydin I, Kirbas A, Efe H, Sehitoglu I, Yuce S. Topiramate has protective effect on renal injury. Bratisl Lek Listy. 2015;116(4):259-63. doi: 10.4149/bll_2015_050.
  70. Sehitoglu I, Tumkaya L, Bedir R, Kalkan Y, Cure MC, Yucel AF, Zorba OU, Yuce S, Cure E. Zoledronic acid aggravates kidney damage during ischemia reperfusion injury in rat. J Environ Pathol Toxicol Oncol. 2015;34(1):53-61. doi: 10.1615/jenvironpatholtoxicoloncol.2015012424.
  71. Sehitoglu I, Bedir R, Ural UM, Gucer H, Yurdakul C, Cure MC, Cure E, Yuce S, Sahin FK. Relationships between C-kit expression and mean platelet volume in benign, preneoplastic and neoplastic endometrium. Asian Pac J Cancer Prev. 2015;16(4):1495-9. doi: 10.7314/apjcp.2015.16.4.1495.
  72. Erturk A, Cure E, Parlak E, Cumhur Cure M, Baydur Sahin S, Yuce S. Clinical significance of neutrophil gelatinase-associated lipocalin in Crimean-Congo hemorrhagic Fever. Biomed Res Int. 2015;2015:374010. doi: 10.1155/2015/374010.
  73. Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E. Noncardiac Pulmonary Edema induced by Sitagliptin Treatment. J Family Med Prim Care. 2014 Oct-Dec;3(4):456-7. doi: 10.4103/2249-4863.148149.
  74. Erturk A, Cure E, Cure MC, Parlak E, Kurt A, Ogullar S. The association between serum YKL-40 levels, mean platelet volume, and c-reactive protein in patients with cellulitis. Indian J Med Microbiol. 2015 Feb;33 Suppl:61-6. doi: 10.4103/0255-0857.150891.
  75. Yuce S, Cure E, Sezgin H, Cure MC, Algün E. Has the Required Importance Been given to the Diagnosis and Treatment of Prediabetes? Int J Prev Med. 2014 Aug;5(8):1071-2.
  76. Erturk A, Cure E, Parlak E, Cure MC, Yuce S, Kizilkaya B. Serum resistin levels may be new prognostic factor of crimean-congo hemorrhagic fever. Int J Clin Exp Med. 2014 Oct 15;7(10):3536-42.
  77. Sahin FK, Sahin SB, Balik G, Ural UM, Tekin YB, Cure MC, Senturk S, Yuce S, Cure E. Does low pentraxin-3 levels associate with polycystic ovary syndrome and obesity? Int J Clin Exp Med. 2014 Oct 15;7(10):3512-9.
  78. Sahin S, Belice T, Ogullar S, Ayaz T, Cure E. Syncope in a patient with spontaneous hemorrhage into a thyroid nodule. Hippokratia. 2014 Apr;18(2):177-9.
  79. Cure E, Cure MC, Tumkaya L, Kalkan Y, Aydin I, Kirbas A, Yilmaz A, Yuce S, Gokce MF. Topiramate ameliorates abdominal aorta cross-clamping induced liver injury in rats. Saudi J Gastroenterol. 2014 Sep-Oct;20(5):297-303. doi: 10.4103/1319-3767.141690.
  80. Cure E, Kirbas A, Tumkaya L, Cure MC, Sahin OZ, Kalkan Y, Yuce S, Altuner D. Effect of infliximab against cisplatin-induced nephrotoxicity. Saudi Med J. 2014 Sep;35(9):953-8.
  81. Aktan AH, Ozcelik A, Cure E, Cure MC, Yuce S. Profound hypoglycemia-ınduced by vaccinium corymbosum juice and laurocerasus fruit. Indian J Pharmacol. 2014 Jul-Aug;46(4):446-7. doi: 10.4103/0253-7613.135963.
  82. Ertürk A, Çiçek AÇ, Gümüş A, Cüre E, Şen A, Kurt A, Karagöz A, Aydoğan N, Sandallı C, Durmaz R. Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units. Ann Clin Microbiol Antimicrob. 2014 Jul 22;13:36. doi: 10.1186/s12941-014-0036-2.
  83. Aydin I, Kalkan Y, Ozer E, Yucel AF, Pergel A, Cure E, Cure MC, Sahin DA. The protective effect of infliximab on cisplatin-induced intestinal tissue toxicity. Eur Rev Med Pharmacol Sci. 2014;18(14):2076-83.
  84. Erturk A, Akdogan RA, Parlak E, Cure E, Cumhur Cure M, Ozturk C. Is increasing the dose of Entecavir effective in partial virological responders? Drug Des Devel Ther. 2014 May 29;8:621-5. doi: 10.2147/DDDT.S61045.
  85. Erturk A, Cure E, Ozkurt Z, Parlak E, Cure MC. Serum fibronectin levels in acute and chronic viral hepatitis patients. Malays J Med Sci. 2014 Jan;21(1):29-36.
  86. Cumhur Cure M, Cure E, Yuce S, Yazici T, Karakoyun I, Efe H. Mean platelet volume and vitamin D level. Ann Lab Med. 2014 Mar;34(2):98-103. doi: 10.3343/alm.2014.34.2.98.
  87. Cure E, Cumhur Cure M, Tumkaya L, Kalkan Y, Aydin I, Kirbas A, Yilmaz A, Yuce S, Yücel AF. Adalimumab ameliorates abdominal aorta cross clamping which induced liver injury in rats. Biomed Res Int. 2014;2014:907915. doi: 10.1155/2014/907915.
  88. Cure MC, Tufekci A, Cure E, Kirbas S, Ogullar S, Kirbas A, Unal H, Yuce S, Cakmak S. Low-density lipoprotein subfraction, carotid artery intima-media thickness, nitric oxide, and tumor necrosis factor alpha are associated with newly diagnosed ischemic stroke. Ann Indian Acad Neurol. 2013 Oct;16(4):498-503. doi: 10.4103/0972-2327.120438.
  89. Cüre E, Ciçek Y, Cumhur Cüre M, Yüce S, Kırbaş A, Yılmaz A. The evaluation of relationship between adiponectin levels and epicardial adipose tissue thickness with low cardiac risk in Gilbert`s syndrome: an observational study. Anadolu Kardiyol Derg. 2013 Dec;13(8):791-6. doi: 10.5152/akd.2013.266.
  90. Cure E, Balik MS, Cumhur Cure M, Guvercin Y, Erkut A, Yuce S, Keskin D. Is the mean platelet volume predictive of hip fractures in the elderly? Ann Lab Med. 2013 Sep;33(5):367-70. doi: 10.3343/alm.2013.33.5.367.
  91. Cüre E, Yüce S, Ciçek Y, Cüre MC. The effect of Gilbert’s syndrome on the dispersions of QT interval and P-wave: an observational study. Anadolu Kardiyol Derg. 2013 Sep;13(6):559-65. doi: 10.5152/akd.2013.180.
  92. Cure E, Yuce S, Cure MC. Severe hypocalcemia associated with zoledronic acid treatment in a patient with a risk of fracture due to drug-induced osteopenia. Minerva Endocrinol. 2013 Jun;38(2):217-8.
  93. Cure MC, Cure E, Kirbas A, Cicek AC, Yuce S. The effects of Gilbert’s syndrome on the mean platelet volume and other hematological parameters. Blood Coagul Fibrinolysis. 2013 Jul;24(5):484-8. doi: 10.1097/MBC.0b013e32835e4230.
  94. Cure MC, Cure E, Kirbas A, Yazici T, Yuce S. Requests for tumor marker tests in Turkey without indications and frequency of elevation in benign conditions. Asian Pac J Cancer Prev. 2012;13(12):6485-9. doi: 10.7314/apjcp.2012.13.12.6485.
  95. Gökalp O, Gunes A, Cam H, Cure E, Aydın O, Tamer MN, Scordo MG, Dahl ML. Mild hypoglycaemic attacks induced by sulphonylureas related to CYP2C9, CYP2C19 and CYP2C8 polymorphisms in routine clinical setting. Eur J Clin Pharmacol. 2011 Dec;67(12):1223-9. doi: 10.1007/s00228-011-1078-4.
  96. Kutun S, Ulucanlar H, Celik A, Cure E, Kockar MC, Cetin A. Effects of octreotide on healing of mechanical ileus in rats. Saudi Med J. 2008 Apr;29(4):539-43.
  97. Sahin M, Yildiz M, Tunc SE, Cerci S, Suslu H, Cure E, Kutlucan A. The usefulness of Tc-99m-MDP bone scintigraphy in detection of articular involvement of Behçet’s disease. Ann Nucl Med. 2006 Dec;20(10):649-53. doi: 10.1007/BF02984675.
  98. Akdoğan M, Tamer MN, Cüre E, Cüre MC, Köroğlu BK, Delibaş N. Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism. Phytother Res. 2007 May;21(5):444-7. doi: 10.1002/ptr.2074.
  99. Okudan B, Sahin M, Ozbek FM, Keskin AU, Cüre E. Detection of alveolar epithelial injury by Tc-99m DTPA radioaerosol inhalation lung scan in rheumatoid arthritis patients. Ann Nucl Med. 2005 Sep;19(6):455-60. doi: 10.1007/BF02985572.
حجز موعد مع الطبيب